default author photo

Hyolim Kang

Nagasaki University

Katafuchi

Nagasaki

Nagasaki 850-8506

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

100

TOTAL CITATIONS

0

Scholarly Papers (1)

Benefit-Risk of the Live-Attenuated Chikungunya Vaccine Ixchiq for Travel Vaccination and Age-Specific Outbreak Response Immunisation Strategies: A Modelling Study

Number of pages: 62 Posted: 20 Mar 2026
Nagasaki University, London School of Hygiene & Tropical Medicine - Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, Wellcome Trust, London School of Hygiene & Tropical Medicine, International Vaccine Institute, Imperial College London, The INCLEN Trust International, The INCLEN Trust International, World Health Organization, Gorgas Memorial Institute for Health Studies, International Vaccine Institute, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases and London School of Hygiene & Tropical Medicine
Downloads 64 (957,329)

Abstract:

Loading...

Chikungunya, live-attenuated vaccine, benefit-risk analysis, outbreak response immunisation, travel vaccination

Benefit-Risk of the Live-Attenuated Chikungunya Vaccine Ixchiq for Travel Vaccination and Age-Specific Outbreak Response Immunisation Strategies: A Modelling Study

Number of pages: 58 Posted: 28 May 2026
Nagasaki University, London School of Hygiene & Tropical Medicine - Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, Wellcome Trust, London School of Hygiene & Tropical Medicine, International Vaccine Institute, Imperial College London, The INCLEN Trust International, The INCLEN Trust International, World Health Organization, Gorgas Memorial Institute for Health Studies, International Vaccine Institute, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, Federal University of Goias and London School of Hygiene & Tropical Medicine
Downloads 36 (1,430,393)

Abstract:

Loading...

Chikungunya, live-attenuated vaccine, benefit-risk analysis, outbreak responseimmunisation, travel vaccination